Looking at the full-year period, BioFish has successfully delivered 450 tons ofsmolt and post-smolt in 2023, which resulted in revenues of NOK 47.7 million,compared with NOK 20.2 million in 2022. In line with the production plan,BioFish had no smolt deliveries in the fourth quarter, and consequently norevenues were generated for the period.”BioFish has a proven […]
BIOFISH HOLDING AS: Fourth quarter 2023 results Read More »
Financial calendar for BioFish Holding ASFINANCIAL YEAR 202323.05.2024 – Annual Report22.03.2024 – Quarterly Report – Q4FINANCIAL YEAR 202422.08.2024 – Half-yearly Report28.02.2025 – Annual Report08.05.2025 – Annual General Meeting15.05.2024 – Quarterly Report – Q115.11.2024 – Quarterly Report – Q3Updated financial calendar.This information is published pursuant to the requirements set out in theContinuing obligations.
BFISH: Financial calendar Read More »
Reference is made to the stock exchange announcement made 12 February 2024.Biofish Holding AS (the “Company” or “BioFish”) is pleased to announce that therefinancing process has been finalised. The Company has signed agreements forboth a new revolving credit facility of NOK 33 million and the extension of theduration of its existing loan (NOK 51 million)
Johnny Duedahl has been appointed Chief Financial Officer (“CFO”) of BiofishHolding AS (“BioFish”), effective from today, 1 March 2024. Duedahl has servedas interim CFO of BioFish since October 2023. Duedahl holds extensive experience in management and finance leadership roles.His most recent positions include serving as CFO of Nortech AI AS and as CFO ofKvass AS.
BIOFISH HOLDING AS: Johnny Duedahl appointed as new CFO Read More »
Reference is made to the stock exchange notice from Biofish Holding AS (the”Company”) on 13 February 2024 regarding a second exercise period (the “SecondExercise Period”) of the warrants (the “Warrants”) issued from placements in2023. The Company received subscriptions for 13,406,423 new shares by exercise ofWarrants during the Second Exercise Period (the “New Shares”). The share
BIOFISH HOLDING AS: New share capital registered Read More »
Reference is made to the warrants (the “Warrants”) issued by Biofish Holding AS(the “Company”) from placements in 2023, and the notice on 12 January 2024 inconnection with the commencement of a second exercise period (the “SecondExercise Period”), during which holders of Warrants could subscribe for newshares in the Company at a price of NOK 1.10.
BIOFISH HOLDING AS: Exercise of Warrants Read More »
Biofish Holding AS (the “Company”) is pleased to announce that the Company hasreceived a term sheet for a new revolving credit facility of NOK 33 million andan extension of the duration of its existing loan (NOK 51 million) until 31January 2027. The final documentation and commercial terms are still subject to negotiation.However, the Company expects
Biofish Holding AS – Term sheet for revolving credit facility received Read More »
Ole Fredrik Skulstad has on 19 January 2024 sold 500,000 warrants in BiofishHolding AS at a price of NOK 0,10 per warrant. Ole Fredrik Skulstad owns 1,680,964 shares, representing 1.90% ownership inBiofish Holding AS.
BioFish – Primary insiders sale of warrants Read More »
Reference is made to the warrants (the “Warrants”) issued in connection with theprivate placement completed by Biofish Holding AS (the “Company”) in January2023 (the “Private Placement”) and the subsequent offering (the “SubsequentOffering”) and resolved by the extraordinary general meeting of the Company heldon 23 January 2023. Shareholders that have been allocated Warrants have the second
BIOFISH HOLDING AS: Exercise of Warrants Read More »
Fredrik Furustøl has on 9 and 10 January 2024 acquired in total 48,000 shares inBiofish Holding AS at a price of NOK 1,42 per share. Fredrik Furustøl is arelated party of primary insider Ole Fredrik Skulstad. Fredrik Furustøl owns 48,000 shares in Biofish Holding AS.
BioFish – Primary insiders purchase of shares Read More »
